Nota Sjoerd P F T, Kloen Peter
Sjoerd P.F.T. Nota MD, Department of Orthopaedic Surgery, Academic Medical Centre, Amsterdam, the Netherlands.
Arch Bone Jt Surg. 2014 Oct;2(4):250-4. Epub 2014 Oct 15.
Demineralized bone matrix has been successfully commercialized as an alternative bone graft material that not only can function as filler but also as an osteoinductive graft. Numerous studies have confirmed its beneficial use in clinical practice. Heterotopic ossification after internal fixation combined with the use of demineralized bone matrix has not been widely reported. In this paper we describe a 39 year old male who sustained a complex articular fracture that developed clinically significant heterotopic ossification after internal fixation with added demineralized bone matrix. Although we cannot be sure that there is a cause-and-effect relation between demineralized bone matrix and the excessive heterotopic ossification seen in our patient, it seems that some caution in using demineralised bone matrix in similar cases is warranted. Also, given the known inter- and intraproduct variability, the risks and benefits of these products should be carefully weighed.
脱矿骨基质已成功商业化,成为一种替代骨移植材料,它不仅可作为填充物,还可作为骨诱导移植物。大量研究证实了其在临床实践中的有益用途。内固定联合使用脱矿骨基质后发生异位骨化的情况尚未得到广泛报道。在本文中,我们描述了一名39岁男性,他遭受了复杂的关节骨折,在内固定并添加脱矿骨基质后出现了具有临床意义的异位骨化。尽管我们不能确定脱矿骨基质与我们患者中出现的过度异位骨化之间存在因果关系,但在类似病例中使用脱矿骨基质时似乎仍需谨慎。此外,鉴于已知产品间和产品内的变异性,应仔细权衡这些产品的风险和益处。